Roland Buelow

6.9k total citations
120 papers, 4.9k citations indexed

About

Roland Buelow is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Roland Buelow has authored 120 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 44 papers in Immunology and 29 papers in Surgery. Recurrent topics in Roland Buelow's work include Heme Oxygenase-1 and Carbon Monoxide (44 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Roland Buelow is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (44 papers), Monoclonal and Polyclonal Antibodies Research (26 papers) and Organ Transplantation Techniques and Outcomes (18 papers). Roland Buelow collaborates with scholars based in United States, France and Germany. Roland Buelow's co-authors include Suhasini Iyer, Jerzy W. Kupiec‐Weglinski, Ronald W. Busuttil, Mohamed H. Sayegh, Wayne W. Hancock, Hans‐Dieter Volk, Laurence A. Turka, Farin Amersi, Ana J. Coito and Bibo Ke and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Roland Buelow

117 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Buelow United States 39 2.7k 1.3k 1.0k 718 589 120 4.9k
Ulrich Kunzendorf Germany 36 2.4k 0.9× 665 0.5× 1.6k 1.6× 424 0.6× 617 1.0× 118 5.6k
Patrick D. Walker United States 42 1.4k 0.5× 538 0.4× 514 0.5× 224 0.3× 286 0.5× 122 5.1k
Véronique Bailly United States 22 1.8k 0.7× 535 0.4× 634 0.6× 142 0.2× 187 0.3× 24 4.3k
Anwar Farhood United States 50 1.9k 0.7× 2.3k 1.7× 1.8k 1.7× 167 0.2× 161 0.3× 93 8.5k
Niels Grunnet Denmark 40 1.1k 0.4× 662 0.5× 1.1k 1.1× 504 0.7× 262 0.4× 217 5.1k
J Bariéty France 45 1.6k 0.6× 924 0.7× 1.6k 1.6× 317 0.4× 453 0.8× 221 7.0k
Andreas Geier Germany 41 1.4k 0.5× 1.8k 1.3× 400 0.4× 355 0.5× 406 0.7× 209 6.7k
Y Morishima Japan 42 1.1k 0.4× 289 0.2× 1.3k 1.2× 228 0.3× 197 0.3× 235 6.0k
Thomas Boyer United States 43 1.2k 0.5× 2.6k 2.0× 150 0.1× 144 0.2× 229 0.4× 157 7.5k
M. J. Phillips Canada 29 973 0.4× 1.4k 1.1× 412 0.4× 247 0.3× 298 0.5× 79 7.0k

Countries citing papers authored by Roland Buelow

Since Specialization
Citations

This map shows the geographic impact of Roland Buelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Buelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Buelow more than expected).

Fields of papers citing papers by Roland Buelow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Buelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Buelow. The network helps show where Roland Buelow may publish in the future.

Co-authorship network of co-authors of Roland Buelow

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Buelow. A scholar is included among the top collaborators of Roland Buelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Buelow. Roland Buelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalvi, Pranjali, Kevin Dang, James P. Allison, et al.. (2025). Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD. Frontiers in Immunology. 16. 1640611–1640611.
2.
Dang, Kevin, Laure‐Hélène Ouisse, Benjamin Buelow, et al.. (2022). TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity. mAbs. 14(1). 2095949–2095949. 19 indexed citations
3.
Ouisse, Laure‐Hélène, Laetitia Gautreau‐Rolland, Marie‐Claire Devilder, et al.. (2017). Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies. BMC Biotechnology. 17(1). 3–3. 37 indexed citations
4.
Ménoret, Séverine, Laurent Tesson, Séverine Remy, et al.. (2010). Characterization of immunoglobulin heavy chain knockout rats. European Journal of Immunology. 40(10). 2932–2941. 49 indexed citations
5.
Weiß, Paul, Nigel Courtenay-Luck, Roland Buelow, et al.. (2006). Session 5: Molecular biology – II. Human Antibodies. 15(1-2). 19–28. 1 indexed citations
6.
Kotsch, Katja, Maja Francuski, Andreas Pascher, et al.. (2006). Improved Long-Term Graft Survival after HO-1 Induction in Brain-Dead Donors. American Journal of Transplantation. 6(3). 477–486. 55 indexed citations
7.
Bédard, Eric L.R., Jifu Jiang, Neil Parry, et al.. (2005). Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection. Transplant International. 18(3). 341–349. 18 indexed citations
8.
Araujo, Jesús A., Lingzhong Meng, Aaron D. Tward, et al.. (2003). Systemic Rather Than Local Heme Oxygenase-1 Overexpression Improves Cardiac Allograft Outcomes in a New Transgenic Mouse. The Journal of Immunology. 171(3). 1572–1580. 73 indexed citations
9.
Brasile, Lauren, Roland Buelow, Bart M. Stubenitsky, & G. Kootstra. (2003). Induction of heme oxygenase-1 in kidneys during ex vivo warm perfusion. Transplantation. 76(8). 1145–1149. 35 indexed citations
10.
11.
Kato, Hirohisa, Farin Amersi, Roland Buelow, et al.. (2001). Heme Oxygenase-1 Overexpression Protects Rat Livers from Ischemia/Reperfusion Injury with Extended Cold Preservation. American Journal of Transplantation. 1(2). 121–128. 159 indexed citations
12.
Brouard, Sophie, María Cristina Cuturi, Pascale Pignon, et al.. (1999). PROLONGATION OF HEART XENOGRAFT SURVIVAL IN A HAMSTER-TO-RAT MODEL AFTER THERAPY WITH A RATIONALLY DESIGNED IMMUNOSUPPRESSIVE PEPTIDE1. Transplantation. 67(12). 1614–1618. 15 indexed citations
13.
Iyer, Suhasini, Jacky Woo, Lan Gao, et al.. (1998). Characterization and Biological Significance of Immunosuppressive Peptide D2702.75–84(E → V) Binding Protein. Journal of Biological Chemistry. 273(5). 2692–2697. 49 indexed citations
14.
Cuturi, M. C., J Woo, Suhasini Iyer, et al.. (1998). Prolongation of Rat Allograft Survival Following Therapy with Rationally Designed Immunosuppressive Peptides: Analysis of the Mechanism of Action.. Transplantation. 65(Supplement). 172–172. 1 indexed citations
15.
Magee, Colm, et al.. (1998). IN VITRO AND IN VIVO IMMMUNOMODULATORY EFFECTS OF RDP 1258, A NOVEL SYNTHETIC PEPTIDE. Transplantation. 65(Supplement). 172–172. 1 indexed citations
16.
17.
Giral, Magali, María Cristina Cuturi, Jean‐Michel Nguyen, et al.. (1997). DECREASED CYTOTOXIC ACTIVITY OF NATURAL KILLER CELLS IN KIDNEY ALLOGRAFT RECIPIENTS TREATED WITH HUMAN HLA-DERIVED PEPTIDE. Transplantation. 63(7). 1004–1011. 20 indexed citations
18.
19.
Murphy, Barbara, Kyung Sik Kim, Roland Buelow, Mohamed H. Sayegh, & Wayne W. Hancock. (1997). SYNTHETIC MHC CLASS I PEPTIDE PROLONGS CARDIAC SURVIVAL AND ATTENUATES TRANSPLANT ARTERIOSCLEROSIS IN THE LEWIS???FISCHER 344 MODEL OF CHRONIC ALLOGRAFT REJECTION. Transplantation. 64(1). 14–19. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Kunzendorf Breakdown of academic impact, for papers by Patrick D. Walker Breakdown of academic impact, for papers by Véronique Bailly Breakdown of academic impact, for papers by Anwar Farhood Breakdown of academic impact, for papers by Niels Grunnet Breakdown of academic impact, for papers by J Bariéty Breakdown of academic impact, for papers by Andreas Geier Breakdown of academic impact, for papers by Y Morishima Breakdown of academic impact, for papers by Thomas Boyer Breakdown of academic impact, for papers by M. J. Phillips
Rankless by CCL
2026